Although these myogenic defects may be legitimately considered secondary to changes in the denervated stem cell niche, the recent discovery of the moonlighting activity of TARDBP (a major ALS-causative gene) in muscle regeneration has bolstered the argument for the implication of myogenesis in the pathophysiology of ALS [81]. Here, TARDBP is linked to amyotrophic lateral sclerosis.